tiprankstipranks
Biodexa Pharmaceuticals (BDRX)
NASDAQ:BDRX
US Market
BDRX
Biodexa Pharmaceuticals
RESEARCH TOOLSreports

Biodexa Pharmaceuticals (BDRX) Financial Statements

539 Followers

Biodexa Pharmaceuticals Financial Overview

Biodexa Pharmaceuticals's market cap is currently $1.52M. The company's EPS TTM is $; its P/E ratio is -0.19; Biodexa Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue£ 0.00£ 0.00£ 381.00K£ 699.00K£ 578.00K
Gross Profit£ -184.86K£ -5.44M£ -3.69M£ -4.41M£ -4.08M
Operating Income£ -8.27M£ -9.20M£ -8.01M£ -8.93M£ -7.00M
EBITDA£ -8.08M£ -9.08M£ -7.16M£ -8.26M£ -5.66M
Net Income£ -6.24M£ -5.73M£ -7.08M£ -7.66M£ -5.46M
Balance Sheet
Cash & Short-Term Investments£ 8.52M£ 1.67M£ 5.97M£ 2.84M£ 10.06M
Total Assets£ 18.15M£ 14.78M£ 10.54M£ 5.53M£ 12.91M
Total Debt£ 60.89K£ 727.00K£ 464.00K£ 624.00K£ 766.00K
Net Debt£ -8.46M£ -942.00K£ -5.51M£ -2.21M£ -9.29M
Total Liabilities£ 6.76M£ 6.46M£ 5.86M£ 2.36M£ 2.46M
Stockholders' Equity£ 11.38M£ 8.32M£ 4.68M£ 3.16M£ 10.45M
Cash Flow
Free Cash Flow£ -5.40M£ -13.04M£ -7.09M£ -7.11M£ -6.33M
Operating Cash Flow£ -5.39M£ -12.26M£ -6.83M£ -7.05M£ -6.01M
Investing Cash Flow£ -658.25K£ -598.00K£ -265.00K£ -220.00K£ -278.00K
Financing Cash Flow£ 12.77M£ 8.56M£ 10.23M£ 47.00K£ 8.80M
Currency in GBP

Biodexa Pharmaceuticals Earnings and Revenue History

Income Statement >

Biodexa Pharmaceuticals Debt to Assets

Balance Sheet >

Biodexa Pharmaceuticals Cash Flow

Cash Flow >

Biodexa Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >